Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01833234 · ClinicalTrials.gov registry record
Epilepsy Impact Scale
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 51
- Enrollment target
NCT01833234: Completed study, sponsored by Stanford University.
NCT01833234 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 51 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01833234 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 51 participants
- Enrollment target
Study Summary
The investigators are developing a questionnaire that can quickly measure the impact that epilepsy has on a person's life. This questionnaire will be useful in following whether the impact of epilepsy increases, decreases or stays the same over time. The results also may point out areas that would benefit from discussion or attention in visits with your doctor.
Interventions
- OTHER Interviews and questionnaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2012-07 |
| Est. Completion | 2014-09 |
What the finished NCT01833234 record still lists
NCT01833234 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 51 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Interviews and questionnaires is the first listed.
NCT01833234 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01833234 about?
NCT01833234 is a clinical study titled "Epilepsy Impact Scale". The investigators are developing a questionnaire that can quickly measure the impact that epilepsy has on a person's life. This questionnaire will be useful in following whether the impact of epilepsy increases, decreases or stays the same over time. The results also may point out areas that would b...
What is the current status of trial NCT01833234?
This trial is currently completed. The enrollment target is 51 participants. The study started on 2012-07. Estimated completion is 2014-09.
What interventions are being tested in trial NCT01833234?
The interventions under investigation include: Interviews and questionnaires (OTHER).
Who is sponsoring clinical trial NCT01833234?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia